Digestive & Intestinal Remedies (Pharmacies) - Qatar

  • Qatar
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$38.24m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.48%, resulting in a market volume of US$43.22m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$13.97 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Qatar is experiencing steady growth due to changing customer preferences and increasing awareness about digestive health.

Customer preferences:
Customers in Qatar are increasingly seeking out digestive and intestinal remedies to address common gastrointestinal issues such as indigestion, bloating, and acid reflux. This is driven by a growing awareness of the importance of digestive health and its impact on overall well-being. Additionally, the convenience of purchasing these remedies from local pharmacies further contributes to their popularity among customers.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Qatar is the rising demand for natural and herbal remedies. Customers are becoming more conscious of the ingredients used in these products and are opting for those that are derived from natural sources. This trend aligns with the global shift towards natural and organic products in the healthcare industry. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive and intestinal remedies. Pharmacies in Qatar are expanding their product offerings to cater to the growing demand from customers. This allows customers to easily access these remedies without the need for a prescription, thereby enhancing convenience and accessibility.

Local special circumstances:
Qatar has a high prevalence of gastrointestinal disorders, which is driving the demand for digestive and intestinal remedies. Factors such as a sedentary lifestyle, unhealthy eating habits, and stress contribute to the occurrence of these disorders. As a result, customers are actively seeking out remedies to alleviate their symptoms and improve their digestive health. Furthermore, Qatar has a well-developed healthcare infrastructure, with a strong emphasis on preventive care and wellness. This has led to increased awareness about the importance of digestive health and the availability of remedies to address related issues. Pharmacies play a crucial role in providing these remedies to customers, making them easily accessible to the population.

Underlying macroeconomic factors:
Qatar's growing population and rising disposable income are key macroeconomic factors driving the growth of the Digestive & Intestinal Remedies market. As the population increases, so does the demand for healthcare products and services. Additionally, the country's high per capita income allows individuals to afford these remedies, further fueling market growth. Moreover, the government of Qatar has been actively promoting healthcare and wellness initiatives, which includes raising awareness about digestive health. This support from the government creates a conducive environment for the growth of the Digestive & Intestinal Remedies market in the country. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Qatar is witnessing growth due to changing customer preferences, increasing awareness about digestive health, and the availability of over-the-counter remedies. The local special circumstances, such as the high prevalence of gastrointestinal disorders and a well-developed healthcare infrastructure, further contribute to market growth. Additionally, underlying macroeconomic factors such as population growth and rising disposable income are driving the demand for these remedies in the country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)